This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

By G Stocker. Price, $5.70. Pp 152. Georg Thieme Verlag, Stuttgart, Germany, 1971.

Otto Appenzeller, MD, PhD, Reviewer

Arch Neurol. 1971;25(3):286.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In spite of vast sums and considerable effort, the treatment of strokes remains unsatisfactory. Ingenious methods have been devised to measure cerebral blood flow, and these have yielded a wealth of information which, however, has yet to find use in the management of stroke. No wonder, then, when a pill reputed to increase cerebral blood flow is marketed, international symposia are soon organized to review its efficiency in the treatment of stroke.

The gathering was large and scientifically undistinguished; the papers ranged appropriately from anecdotal to uncontrolled studies. Reaction times were studied before and after cyclandelate therapy, and any changes were taken to equate with cortical functional improvement. Most authors limited themselves to patients with so-called arteriosclerotic dementia. No allowance was made for the incredible variety of deficits often found in such patients. Double-blind studies of the effects of cyclandelate were not particularly favored, and the effects of continuation or . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?